Diagnostic test for ovarian cancer

Thursday, 01 January, 2009 | Supplied by: Manalto Inc

The OvPlex Panel is an early detection test for ovarian cancer, developed by HealthLinx in collaboration with ARL Pathology.

The test works by measuring five different biomarkers (proteins) in blood that are associated with ovarian cancer. It then builds a diagnostic based on that information rather than relying on a single marker for the disease.

Results are available within a fortnight.

Online: www.healthlinx.com.au
Phone: 03 9208 4200

Navinci NaveniFlex Tissue Red proximity ligation assay kit

The kit enables fluorescence visualisation of protein–protein interactions or...

Bio-Rad Laboratories StarBright Dyes for spectral flow cytometry

The range provides users with more options when designing spectral flow cytometry panels,...

MaxWell Biosystems MaxOne+ HD-MEA Chip

The MaxOne⁺ HD-MEA Chip provides an upgraded performance and user experience through...

Content from other channels on our network

New CEO for Sydney Water

Cardboard creates sustainable construction material

Tyre recycling project addresses mining industry waste

How AI is empowering renewable energy in Australia

Australia's 2035 climate target announced

South East Melbourne claims title as nation's top manufacturing hub

Victoria approves its largest grid battery system to date

Yokogawa technology to go to the Moon

Government announces $1.1bn for cleaner fuel production

ABB Robotics invests in vision AI company

Fine Food recap: success for Australian food logistics business

Exploring the impact of packaging on broccoli rabe florets

Beany flavour study to enhance the appeal of soy-based foods

South East Melbourne emerges as Australia's top manufacturing zone

Not all mercury is toxic: bluefin tuna study reveals more